Skip to main content

Advertisement

ADVERTISEMENT

News

NuShield (Wound) - Organogenesis 

https://www.magonlinelibrary.com/doi/full/10.12968/jowc.2024.0139

Organogenesis announces the publication of 218-patient RCT results demonstrating the safety and efficacy of NuShield for DFUs. The company believes the study satisfies Medicare coverage requirements under the proposed Local Coverage Determinations (LCDs). JWC

Advertisement

Advertisement

Advertisement